Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

  • Presentation

Role of Androgens and Hormones in Acne and Androgenetic Alopecia

Description

In this presentation, Dr. Larry Green, a clinical professor of dermatology, discusses the role of androgens and hormones in acne and androgenetic alopecia. The session includes a breakdown of the pathogenesis of these conditions, focusing on the mechanisms by which hormones like testosterone and its derivatives affect skin physiology and sebaceous gland function. Dr. Green highlights the importance of anti-androgens in treating acne, emphasizing their ability to address various aspects of acne production by influencing follicular desquamation, reducing inflammation, and regulating sebum production. He describes the oral and topical anti-androgen therapies available, including the use of oral contraceptives and spironolactone, noting their mechanisms of action and efficacy. The talk details the safety of these treatments, including the risks associated with oral contraceptives and spironolactone, while emphasizing the therapeutic role of spironolactone across all acne types, not just hormonal acne in women. Furthermore, the discussion touches upon antibiotic stewardship in acne treatment, advocating for limited antibiotic courses and the potential benefits of probiotics. The presentation concludes with a call to ensure that treatment options effectively address the multifactorial nature of acne without relying solely on antibiotics.

View more

Conclusions

  • Androgens significantly contribute to the pathogenesis of acne and androgenic alopecia.
  • Local concentrations and ratios of androgens to estrogens, rather than systemic levels, are correlated with acne severity.
  • Anti-androgen therapies can effectively target multiple aspects of acne production, including sebaceous gland activity and follicular desquamation.
  • Oral contraceptives containing ethinyl estradiol and a progestin are effective in treating acne by reducing free testosterone levels.
  • Spironolactone is an effective treatment for acne that works through multiple mechanisms including inhibition of androgen receptors and reducing testosterone production.
  • The safety profile of spironolactone shows no increased risk for certain cancers, including breast and ovarian cancers.
  • Topical anti-androgens, such as clascoterone, show promise in reducing acne-related inflammation and sebum production.
  • There is a need for antibiotic stewardship in acne treatment to mitigate resistance, with a recommended duration of antibiotic use limited to three months.
  • DELROSSO,J KIRCIK,L STEIN-GOLD,L ET AL JDD MARCH 2020 | VOLUME 19 | ISSUE 3
  • CERUTI JM ET AL. ANDROGENS AND ANDROGEN RECEPTOR ACTION IN SKIN AND HAIR FOLLICLES. MOL CELL ENDOCRIN, 2018;465:122-33
  • ZOUBOULIS CHC, DEGITZ K. ANDROGEN ACTION ON HUMAN SKIN -FROM BASIC RESEARCH TO CLINICAL SIGNIFICANCE. EXP DERMATOL 2004: 13 (SUPPL. 4): 5-10
  • Gollnick H, Cunliffe W, Berson D, et al. J Am Acad Derm. 2003;49(Suppl 1):S1-37.
  • Elsaie ML. Hormonal treatment of acne vulgaris: an update. Clin Cosmet Investig Dermatol. 2016;9:241-8.
  • ARRINGTON ET AL JAAD, 2012
  • DASH G, PATIL A, ETAL IDD JUNE 2022 VOL 21 ISSUE 6 618-623
  • GARG ET AL: I AM ACAD DERMATOL 2021;84:1348-55
  • DRENO ET AL ACTA DERM VENEREOL 2024; 104: ADV26002.
  • BOMMAREDDY K, HAMADE H, LOPEZ-OLIVIO M, ET AL. JAMA DERMATOL. 2022;158(3):275-282
  • KRUNIC A, CIUREA A ETAL EFFICACY AND TOLERANCE OF ACNE TREATMENT USING BOTH SPIRONOLACTONE AND A COMBINED OCP CONTAINING DROSPIRENONE JAAD 2008:VOL 58 P 60-62
  • YOLDIMER,T DOI: 10.1080/13697137.2021.1915273
  • TUCHAYI SM, MAKRANTONAKI E, GANCEVICIENE R, ET AL. NAT REV DIS PRIME.2015;1:15029.